The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global GPCR-targeting Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global GPCR-targeting Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1749142

No of Pages : 100

Ask Your Query

Synopsis
The global GPCR-targeting Drug market size was valued at USD 413.6 million in 2022 and is forecast to a readjusted size of USD 491.3 million by 2029 with a CAGR of 2.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

GPCRs or G protein-coupled receptors are proteins located on the cell surface that recognize extracellular substances and transmit signals across the cell membrane. GPCRs do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, and communication with other cells. This brings on adjustments in the body to adapt to the environmental changes such as increased heart rate when feeling threatened or change in vision in response to dim light.

This report is a detailed and comprehensive analysis for global GPCR-targeting Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global GPCR-targeting Drug market size and forecasts, in consumption value ($ Million), 2018-2029
  • Global GPCR-targeting Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
  • Global GPCR-targeting Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
  • Global GPCR-targeting Drug market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for GPCR-targeting Drug
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global GPCR-targeting Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PerkinElmer, Thermo Fisher Scientific, Merck, BD Biosciences and Molecular Devices, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

GPCR-targeting Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Reagent Test Kit
  • Substrate

Market segment by Application

  • Oncology
  • Cardiovascular
  • Central Nervous
  • Other

Market segment by players, this report covers

  • PerkinElmer
  • Thermo Fisher Scientific
  • Merck
  • BD Biosciences
  • Molecular Devices
  • Promega
  • Qiagen
  • Abcam
  • Corning
  • Discoverx
  • Cisbio

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe GPCR-targeting Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of GPCR-targeting Drug, with revenue, gross margin and global market share of GPCR-targeting Drug from 2018 to 2023.
Chapter 3, the GPCR-targeting Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and GPCR-targeting Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of GPCR-targeting Drug.
Chapter 13, to describe GPCR-targeting Drug research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of GPCR-targeting Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of GPCR-targeting Drug by Type
1.3.1 Overview: Global GPCR-targeting Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global GPCR-targeting Drug Consumption Value Market Share by Type in 2022
1.3.3 Reagent Test Kit
1.3.4 Substrate
1.4 Global GPCR-targeting Drug Market by Application
1.4.1 Overview: Global GPCR-targeting Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Oncology
1.4.3 Cardiovascular
1.4.4 Central Nervous
1.4.5 Other
1.5 Global GPCR-targeting Drug Market Size & Forecast
1.6 Global GPCR-targeting Drug Market Size and Forecast by Region
1.6.1 Global GPCR-targeting Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global GPCR-targeting Drug Market Size by Region, (2018-2029)
1.6.3 North America GPCR-targeting Drug Market Size and Prospect (2018-2029)
1.6.4 Europe GPCR-targeting Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific GPCR-targeting Drug Market Size and Prospect (2018-2029)
1.6.6 South America GPCR-targeting Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa GPCR-targeting Drug Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 PerkinElmer
2.1.1 PerkinElmer Details
2.1.2 PerkinElmer Major Business
2.1.3 PerkinElmer GPCR-targeting Drug Product and Solutions
2.1.4 PerkinElmer GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 PerkinElmer Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific GPCR-targeting Drug Product and Solutions
2.2.4 Thermo Fisher Scientific GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck GPCR-targeting Drug Product and Solutions
2.3.4 Merck GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments and Future Plans
2.4 BD Biosciences
2.4.1 BD Biosciences Details
2.4.2 BD Biosciences Major Business
2.4.3 BD Biosciences GPCR-targeting Drug Product and Solutions
2.4.4 BD Biosciences GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BD Biosciences Recent Developments and Future Plans
2.5 Molecular Devices
2.5.1 Molecular Devices Details
2.5.2 Molecular Devices Major Business
2.5.3 Molecular Devices GPCR-targeting Drug Product and Solutions
2.5.4 Molecular Devices GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Molecular Devices Recent Developments and Future Plans
2.6 Promega
2.6.1 Promega Details
2.6.2 Promega Major Business
2.6.3 Promega GPCR-targeting Drug Product and Solutions
2.6.4 Promega GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Promega Recent Developments and Future Plans
2.7 Qiagen
2.7.1 Qiagen Details
2.7.2 Qiagen Major Business
2.7.3 Qiagen GPCR-targeting Drug Product and Solutions
2.7.4 Qiagen GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qiagen Recent Developments and Future Plans
2.8 Abcam
2.8.1 Abcam Details
2.8.2 Abcam Major Business
2.8.3 Abcam GPCR-targeting Drug Product and Solutions
2.8.4 Abcam GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Abcam Recent Developments and Future Plans
2.9 Corning
2.9.1 Corning Details
2.9.2 Corning Major Business
2.9.3 Corning GPCR-targeting Drug Product and Solutions
2.9.4 Corning GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Corning Recent Developments and Future Plans
2.10 Discoverx
2.10.1 Discoverx Details
2.10.2 Discoverx Major Business
2.10.3 Discoverx GPCR-targeting Drug Product and Solutions
2.10.4 Discoverx GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Discoverx Recent Developments and Future Plans
2.11 Cisbio
2.11.1 Cisbio Details
2.11.2 Cisbio Major Business
2.11.3 Cisbio GPCR-targeting Drug Product and Solutions
2.11.4 Cisbio GPCR-targeting Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cisbio Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global GPCR-targeting Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of GPCR-targeting Drug by Company Revenue
3.2.2 Top 3 GPCR-targeting Drug Players Market Share in 2022
3.2.3 Top 6 GPCR-targeting Drug Players Market Share in 2022
3.3 GPCR-targeting Drug Market: Overall Company Footprint Analysis
3.3.1 GPCR-targeting Drug Market: Region Footprint
3.3.2 GPCR-targeting Drug Market: Company Product Type Footprint
3.3.3 GPCR-targeting Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global GPCR-targeting Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global GPCR-targeting Drug Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global GPCR-targeting Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global GPCR-targeting Drug Market Forecast by Application (2024-2029)
6 North America
6.1 North America GPCR-targeting Drug Consumption Value by Type (2018-2029)
6.2 North America GPCR-targeting Drug Consumption Value by Application (2018-2029)
6.3 North America GPCR-targeting Drug Market Size by Country
6.3.1 North America GPCR-targeting Drug Consumption Value by Country (2018-2029)
6.3.2 United States GPCR-targeting Drug Market Size and Forecast (2018-2029)
6.3.3 Canada GPCR-targeting Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico GPCR-targeting Drug Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe GPCR-targeting Drug Consumption Value by Type (2018-2029)
7.2 Europe GPCR-targeting Drug Consumption Value by Application (2018-2029)
7.3 Europe GPCR-targeting Drug Market Size by Country
7.3.1 Europe GPCR-targeting Drug Consumption Value by Country (2018-2029)
7.3.2 Germany GPCR-targeting Drug Market Size and Forecast (2018-2029)
7.3.3 France GPCR-targeting Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom GPCR-targeting Drug Market Size and Forecast (2018-2029)
7.3.5 Russia GPCR-targeting Drug Market Size and Forecast (2018-2029)
7.3.6 Italy GPCR-targeting Drug Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific GPCR-targeting Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific GPCR-targeting Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific GPCR-targeting Drug Market Size by Region
8.3.1 Asia-Pacific GPCR-targeting Drug Consumption Value by Region (2018-2029)
8.3.2 China GPCR-targeting Drug Market Size and Forecast (2018-2029)
8.3.3 Japan GPCR-targeting Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea GPCR-targeting Drug Market Size and Forecast (2018-2029)
8.3.5 India GPCR-targeting Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia GPCR-targeting Drug Market Size and Forecast (2018-2029)
8.3.7 Australia GPCR-targeting Drug Market Size and Forecast (2018-2029)
9 South America
9.1 South America GPCR-targeting Drug Consumption Value by Type (2018-2029)
9.2 South America GPCR-targeting Drug Consumption Value by Application (2018-2029)
9.3 South America GPCR-targeting Drug Market Size by Country
9.3.1 South America GPCR-targeting Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil GPCR-targeting Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina GPCR-targeting Drug Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa GPCR-targeting Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa GPCR-targeting Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa GPCR-targeting Drug Market Size by Country
10.3.1 Middle East & Africa GPCR-targeting Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey GPCR-targeting Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia GPCR-targeting Drug Market Size and Forecast (2018-2029)
10.3.4 UAE GPCR-targeting Drug Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 GPCR-targeting Drug Market Drivers
11.2 GPCR-targeting Drug Market Restraints
11.3 GPCR-targeting Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 GPCR-targeting Drug Industry Chain
12.2 GPCR-targeting Drug Upstream Analysis
12.3 GPCR-targeting Drug Midstream Analysis
12.4 GPCR-targeting Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock